Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94.2M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
16.2M
-
Shares change
-
+16.2M
-
Total reported value, excl. options
-
$463M
-
Value change
-
+$463M
-
Number of buys
-
48
-
Price
-
$28.65
Significant Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q3 2018
48 filings reported holding CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock as of Q3 2018.
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.2M shares
of 94.2M outstanding shares and own 17.16% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (3.79M shares), FMR LLC (2.72M shares), PERCEPTIVE ADVISORS LLC (2.59M shares), ORBIMED ADVISORS LLC (1.91M shares), RA CAPITAL MANAGEMENT, LLC (1.7M shares), JANUS HENDERSON GROUP PLC (525K shares), PRICE T ROWE ASSOCIATES INC /MD/ (434K shares), BlackRock Inc. (419K shares), Vanguard Group Inc (248K shares), and Artal Group S.A. (200K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.